slider
slider
slider

Brands Olanzapine

Olanzapine Tablets, 10mg Strenght Antipsychotic 1000 per Bottle

Product # : 72241-0054-11 Class : MDR Distributor : RELIANCE INC Category : Antipsychotics 10 mg Strength Availability : Please contact customer service at info@RxReliance.com to check availability.
Non-Stock Item Information : Any reason may apply
  • This item ships directly from the manufacturer. Additional shipping charges may apply.
  • As a special order from the supplier, the approximate delivery time is 2-4 weeks.
  • For equipment such as beds, lifts, etc., a freight code is required. Please reach out to us to get the code.

$0.00

⚠️ License required to purchase this product.
Volume
Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient
Volume

Product Specifications

Product No. # 72241-0054-11
Manufacturer # 372241054112
Brand Olanzapine
Manufacturer Modavar
Country of Origin India
Application Antipsychotic
Volume 12 Bottles/CS (1000/BT)
Container Type Bottle
Shipping Width 12.08
Shipping Height 15.84
Shipping Depth 10
Dimension UOM IC
Shipping Weight 20.93
Weight UOM LB
Active Ingredients Antipsychotic
Container Type Bottle
Dosage Form Tablet
QTY_Per_Sell 12000
Volume 12 Bottles/CS (1000/BT)
Simply_Medical_Category Antipsychotics 10 mg Strength
Class MDR
Supply_Manager_Category Antipsychotics 10 mg Strength
Supply_Manager_Hierarchy
Pharmaceuticals>Rx>Antipsychotics>Antipsychotic Agent
California_Prop_65 No
Legend_Code Yes
Stock_Status NonStock
FSA_Eligible Yes
GTIN 40372241054110
Ready to Sell Ready to sell
Pureplay CoT Restriction No
Features
  • INDICATIONS:
  • Schizophrenia.
  • Bipolar I Disorder (Manic or Mixed Episodes).
  • Special Considerations in Treating Pediatric Schizophrenia and Bipolar I Disorder.
  • Olanzapine IntraMuscular: Agitation Associated with Schizophrenia and Bipolar I Mania.
  • Olanzapine and Fluoxetine in Combination: Depressive Episodes Associated with Bipolar I Disorder.
  • Olanzapine and Fluoxetine in Combination: Treatment Resistant Depression.